-
Pulmonary function as a continuum of risk: critical care utilization and survival after allogeneic hematopoietic stem cell transplantation - a multicenter cohort study Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-16 Hemang Yadav, Svetlana Herasevich, Zhenmei Zhang, Bradley A. White, Mehrdad Hefazi Torghabeh, William J. Hogan, Philip J. Schulte, Alexander S. Niven, Ognjen Gajic
-
Long term results of a prospective multicenter obervational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study) Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-16 Jürgen Finke, Claudia Schmoor, Francis Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva-Maria Wagner, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
-
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-15 Marie Robin, Simona Iacobelli, Linda Koster, Jakob Passweg, Daniele Avenoso, Keith M. O. Wilson, Urpu Salmenniemi, Peter Dreger, Peter von dem Borne, John A. Snowden, Stephen Robinson, Maria Chiara Finazzi, Thomas Schroeder, Matthew Collin, Matthias Eder, Edouard Forcade, Michael Loschi, Stefania Bramanti, Jose Antonio Pérez-Simón, Tomasz Czerw, Nicola Polverelli, Joanna Drozd-Sokolowska, Kavita Raj
-
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-14 Sabine Fürst, Emmanuelle Bernit, Faezeh Legrand, Angela Granata, Samia Harbi, Raynier Devillier, Valerio Maisano, Benjamin Bouchacourt, Thomas Pagliardini, Djamel Mokart, Claude Lemarié, Boris Calmels, Christophe Picard, Agnès Basire, Borje S. Andersson, Didier Blaise
-
Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-14 Sandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, Christoph Kimmich, Mathias Hänel, Martin Schmidt-Hieber, Hans Salwender, Carmen Flossmann, Hiltrud Heckmann, Franziska Ertel, Andrea Friederich, Sachin Patel, Barbara Thun, Marc S. Raab
-
Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary Syndrome Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-12 S. L. Morris, B. R. Thomas, R. Palanicawandar, S. Whittaker, F. Child, M. Wain, V. Sim, R. Szydlo, S. Mangar, E. Olavarria, S. Lozano Cerrada, A. Muzamil, E. Kanfer
-
Successful use of narsoplimab to treat allogeneic transplant-associated thrombotic microangiopathy while maintaining sirolimus Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-11 Mohammad Alhomoud, Michael Scordo, Miguel-Angel Perales
-
GVHD like skin eruption post-autologous stem cell transplantation Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-11 Johnathan Fraebel, Silvia Park, Rahul Shah, Carlos Prieto-Granada, Emily F. Mason, Salyka Sengsayadeth, Wichai Chinratanalab, Bipin Savani, Reena V. Jayani, Adetola Kassim, Bhagirathbhai R. Dholaria, Tae Kon Kim
-
Life Blood by David Marks: a review Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-09 Anna Castleton
Professor Marks is a colleague, mentor, and friend. His illustrious and influential career as a haematologist and bone marrow transplanter has resulted in numerous scientific publications, and as such he has firmly established his reputation as an experienced and eloquent scientific writer. When asked to review his book, Life Blood – part semi-fictional work, part real life narrative - I realised that
-
Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-09 Thomas Longval, Anne-Claire Leprêtre, Aurélie Ravinet, Amandine Fayard, Edouard Forcade, Tereza Coman, Rabah Redjoul, Ana Berceanu, Nimrod Buchbinder, Guillaume Berlie, Maria Mappoura, Federica Giannotti, Florian Chevillon, Marie Robin, Régis Peffault de Latour, Flore Sicre de Fontbrune
Pure Red Cell Aplasia (PRCA) after ABO-mismatched Hematopoietic Stem Cell Transplant (HSCT) remains a challenge for physicians. It occurs in 7 to 10% [1,2,3] of major or bi-directional ABO-incompatible HSCT. Although it does not affect overall survival [3, 4], post-transplant PRCA significantly impairs patients’ quality of life due to fatigue, iron-overload and increased risk of transfusion complications
-
Von Willebrand factor as a potential predictive biomarker of early complications of endothelial origin after allogeneic hematopoietic stem cell transplantation Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-08 Guillaume Dachy, Marine Vankeerbergen, Nicolas Vanlangendonck, Nicole Straetmans, Catherine Lambert, Cédric Hermans, Xavier Poiré
Vascular endothelial syndrome is a dreadful post-allogeneic hematopoietic stem cell transplant (alloHSCT) complication, which includes capillary leak syndrome (CLS), engraftment syndrome (ES), transplant-associated thrombotic microangiopathy (TA-TMA), idiopathic pneumonia syndrome (IPS) and diffuse alveolar hemorrhages (DAH) [1, 2]. The development of prognostic scores quantifying comorbidities, disease-
-
-
Late-onset pulmonary complications following allogeneic hematopoietic cell transplantation in pediatric patients: a prospective multicenter study Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-07 Véronique Houdouin, Jean Christophe Dubus, Sophie Guilmin Crepon, Fanny Rialland, Bénedicte Bruno, Charlotte Jubert, Philippe Reix, Marlène Pasquet, Catherine Paillard, Dalila Adjaoud, Cyril Schweitzer, Muriel Le Bourgeois, Justine Pages, Adyla Yacoubi, Jean Hugues Dalle, Anne Bergeron, Christophe Delclaux
-
Long-term follow-up of cancer and catastrophic diseases in hematopoietic stem cell donors: a comprehensive matched cohort study Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-07 Sung-Chao Chu, Chia-Jung Hsieh, Chi-Cheng Li, Shang-Hsien Yang, Szu-Chin Li, Woei-Yau Kao, Dian-Kun Li, Yi-Feng Wu, Ruey-Ho Kao, Kuo‐Liang Yang, Tso-Fu Wang
-
Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-05 Anna Sureda, Paul A. Carpenter, Andrea Bacigalupo, Vijaya Raj Bhatt, Josu de la Fuente, Aloysius Ho, Leslie Kean, Jong Wook Lee, Isabel Sánchez-Ortega, Bipin N. Savani, Johannes Schetelig, Edward A. Stadtmauer, Yoshiyuki Takahashi, Yoshiko Atsuta, John Koreth, Nicolaus Kröger, Per Ljungman, Shinichiro Okamoto, Uday Popat, Robert Soiffer, Heather E. Stefanski, Mohamed A. Kharfan-Dabaja
-
Outcomes and prognosis of haploidentical haematopoietic stem cell transplantation in children with FLT3-ITD mutated acute myeloid leukaemia Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-05 Qianwen Shang, Lu Bai, Yifei Cheng, Pan Suo, Guanhua Hu, Chenhua Yan, Yu Wang, Xiaohui Zhang, Lanping Xu, Kaiyan Liu, Xiaojun Huang
-
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1 Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-04 Silvia Park, Su-Yeon Bang, Daehun Kwag, Jong Hyuk Lee, Tong Yoon Kim, Joonyeop Lee, Gi June Min, Sung Soo Park, Seung-Ah Yahng, Young-Woo Jeon, Seung-Hwan Shin, Jae-Ho Yoon, Sung-Eun Lee, Byung Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
-
Role of upfront autologous transplant for peripheral T-cell lymphoma patients achieving a complete remission with first-line therapy: a systematic review and meta-analysis Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-05 L. Girard, Y. J. Koh, L. P. Koh, Y. L. Chee, H. L. Chan, J. Lee, S. de Mel, L. M. Poon, M. Samuel
-
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-04 Jakob R. Passweg, Helen Baldomero, Fabio Ciceri, Rafael de la Cámara, Bertram Glass, Raffaella Greco, Mette D. Hazenberg, Krzysztof Kalwak, Donal P. McLornan, Bénédicte Neven, Zinaida Perić, Antonio M. Risitano, Annalisa Ruggeri, John A. Snowden, Anna Sureda
-
Clostridium butyricum MIYAIRI 588 contributes to the maintenance of intestinal microbiota diversity early after haematopoietic cell transplantation Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-03-02 Kentaro Fukushima, Hayami Kudo, Kentaro Oka, Atsushi Hayashi, Makoto Onizuka, Shinsuke Kusakabe, Akihisa Hino, Motomichi Takahashi, Kiyoshi Takeda, Masaki Mori, Kiyoshi Ando, Naoki Hosen
-
Prevalence of osteoporosis among patients after stem cell transplantation: a systematic review and meta-analysis Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-29 Yu-Mei Yang, Shu-Jin Guo, Rong Xiao, Xi-Jie Yu, Yu-Ping Liu, Ping Shuai
-
How to decrease bone marrow collection volume and risk contaminations via the operating room cell concentration? Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-28 Yoann Grimaud, Flore Sicre de Fontbrune, David Michonneau, Aude Desnoyer, Régis Peffault de Latour, Jérôme Larghero, Justine Nasone, Lionel Faivre
-
Early lymphocyte reconstitution and viral infections in adolescents and adults transplanted for sickle cell disease Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-27 Loïc Vasseur, Alexis Cuffel, Corinne Pondarré, Jean-Hugues Dalle, Florian Chevillon, Aude-Marie Fourmont, Edouard Flamarion, Karima Yakouben, Valérie Guérin-El Khourouj, Florence Morin, Clara Ibanez, Régis Peffault de Latour, Nicolas Boissel, Jean-Benoit Arlet, Hélène Moins-Teisserenc, Sophie Caillat-Zucman, Nathalie Dhédin
Allogeneic hematopoietic stem cell transplantation is a curative therapy for sickle cell disease (SCD). Most reports concern myeloablative (MAC) matched related transplants (MRT) performed in children. Older age is associated with increased toxicity of transplants, resulting in new approaches with reduced intensity conditioning (RIC) regimens for adults. A non-myeloablative (NMA) conditioning regimen
-
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-27 Seth J. Rotz, Neel S. Bhatt, Betty K. Hamilton, Christine Duncan, Mahmoud Aljurf, Yoshiko Atsuta, Kristen Beebe, David Buchbinder, Peggy Burkhard, Paul A. Carpenter, Naeem Chaudhri, Mohamed Elemary, Mahmoud Elsawy, Gregory M. T. Guilcher, Nada Hamad, Amado Karduss, Zinaida Peric, Duncan Purtill, Douglas Rizzo, Morgani Rodrigues, Maria Belén Rosales Ostriz, Nina Salooja, Helene Schoemans, Adriana Seber
-
Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-26 María E. Martínez-Muñoz, Concepción Payares-Herrera, Inés Lipperheide, Rosa Malo de Molina, Isabel Salcedo, Rosalía Alonso, Trinidad Martín-Donaire, Rocío Sánchez, Rocío Zafra, Miguel García-Berciano, Andrea Trisán-Alonso, Manuel Pérez-Torres, Antonio Ramos-Martínez, Piedad Ussetti, Juan J. Rubio, Cristina Avendaño-Solà, Rafael F. Duarte
-
Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-24 Maria Chiara Finazzi, Alessandra Weber, Chiara Pavoni, Anna Grassi, Maria Caterina Micò, Alessandra Algarotti, Federico Lussana, Alessandro Rambaldi
-
Ruxolitinib for the treatment of acute and chronic graft-versus-host disease in children: a systematic review and individual patient data meta-analysis Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-24 Francesco Baccelli, Francesca Gottardi, Edoardo Muratore, Davide Leardini, Antonio Giacomo Grasso, Davide Gori, Tamara Belotti, Arcangelo Prete, Riccardo Masetti
-
Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-24 Alistair Murray, Swe Mar Linn, Benoit Yu, Igor Novitzky-Basso, Jonas Mattsson, Michael Kennah, Mohamed Elemary, Jennifer White, Christopher Lemieux, Kareem Jamani, Dennis Dong Hwan Kim
-
Remuneration of donors for cell and gene therapies: an update on the principles and perspective of the World Marrow Donor Association Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-23 Lina Hamad, Salmah Mahmood Ahmed, Eefke van Eerden, Suzanna M. van Walraven, Laura Machin
-
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-21 Hoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, Harold Lee, Grace Lau, Sze Fai Yip, Bonnie Kho, Chi Kuen Lau, Kwan Hung Leung, Elaine Au, Eric Tse, Joycelyn Sim, Yok Lam Kwong, Chor Sang Chim
-
Return to school practices after hematopoietic cell transplantation: a survey of transplant centers in the United States Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-20 Neel S. Bhatt, Christa L. Meyer, Lih-Wen Mau, Jeffery J. Auletta, K. Scott Baker, Larisa Broglie, Paul A. Carpenter, Sung Won Choi, Christopher E. Dandoy, Steven Devine, Rachel Phelan
-
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-21 Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Bethge, Peter Dreger, Eva-Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P. McLornan, Ibrahim Yakoub-Agha, Mohamad Mohty
-
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-21 Lev Gorfinkel, Sharmila Raghunandan, Benjamin Watkins, Kyle Hebert, Donna S. Neuberg, Brandi Bratrude, Kayla Betz, Alison Yu, Sung W. Choi, Jeffrey Davis, Christine Duncan, Roger Giller, Michael Grimley, Andrew C. Harris, David Jacobsohn, Nahal Lalefar, Nosha Farhadfar, Michael A. Pulsipher, Shalini Shenoy, Aleksandra Petrovic, Kirk R. Schultz, Gregory A. Yanik, Bruce R. Blazar, John T. Horan, Amelia
-
Comparison of haploidentical transplantation and single cord blood transplantation for myelofibrosis Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-20 Kazuki Sakatoku, Makoto Murata, Yutaka Shimazu, Naoyuki Uchida, Satoshi Yoshihara, Yasufumi Uehara, Satoshi Takahashi, Hikaru Kobayashi, Haruyuki Tanaka, Nobuaki Nakano, Fumihiko Ishimaru, Tatsuo Ichinohe, Yoshiko Atsuta, Tokiko Nagamura-Inoue, Hirohisa Nakamae
-
Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-14 Simona Piemontese, Maria Teresa Lupo Stanghellini, Federica Sora, Simona Sica, Jacopo Peccatori, Magda Marcatti, Elisabetta Metafuni, Sabrina Giammarco, Raffaella Greco, Alessandro Bruno, Fabio Ciceri, Andrea Bacigalupo, Patrizia Chiusolo
Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a potentially curative option for patients with hematological malignancies but graft-versus-host disease (GvHD) is still a major cause of morbidity and mortality even in the setting of HLA-matched donors [1]. The ideal GvHD prophylaxis to choose remains to be identified. The most widely used strategy for GvHD prevention, at least in Europe
-
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-15 Meera Mohan, Aniko Szabo, Anannya Patwari, Jean Esselmann, Tanvi Patel, Ramya Bachu, Lisa E. Rein, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Catherine Skoog, Areyl Goff, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Sharmilan Thanendrarajan, Maurizio Zangari, Nirav Shah, Frits van Rhee, Binod Dhakal, Mehdi Hamadani, Anita D’Souza, Carolina Schinke
-
Ruxolitinib in patients with graft versus host disease (GvHD): findings from a compassionate use program Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-15 Thirupathi Pattipaka, Séverine Sarp, Peyman Nakhaei, Sibel Güneş
-
-
Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-13 Giovanna Melica, Elaina Preston, Meighan Palazzo, Kenneth Seier, Florent Malard, Christina Cho, Sean M. Devlin, Molly Maloy, Taylor Borrill, Peter Maslak, Gunjan L. Shah, Miguel-Angel Perales
Myeloablative T cell depleted (CD34-selected) hematopoietic cell transplantation (HCT) is associated with less acute and chronic graft versus host disease (GVHD). We aimed to examine vaccine responses in relation to immune reconstitution and post HCT rituximab administration in this population. This single center retrospective study included 251 patients with hematological malignancies who received
-
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-14 Alexandre E. Malek, Taha Al-Juhaishi, Denái R. Milton, Jeremy L. Ramdial, May Daher, Amanda L. Olson, Samer A. Srour, Gheath Alatrash, Betul Oran, Rohtesh S. Mehta, Issa F. Khouri, Qaiser Bashir, Nina Shah, Stefan O. Ciurea, Gabriela Rondon, Farzaneh Maadani, Chitra Hosing, David Marin, Partow Kebriaei, Katayoun Rezvani, Yago Nieto, Paolo Anderlini, Amin M. Alousi, Muhammad Salman Faisal, Muzaffar
-
A comparison of long-term outcomes by donor type in the era of post-transplantation cyclophosphamide for aggressive adult T-cell leukemia/lymphoma Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-14 Asao Hirose, Hideo Koh, Mika Nakamae, Yasuhiro Nakashima, Mitsutaka Nishimoto, Hiroshi Okamura, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Kentaro Ido, Kazuki Sakatoku, Masayuki Hino, Hirohisa Nakamae
-
Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-14 Yosuke Nakaya, Hirohisa Nakamae, Masashi Nishikubo, Eisei Kondo, Takahiro Fukuda, Nobuhiro Hiramoto, Yasuo Mori, Koji Nagafuji, Tetsuya Eto, Yasushi Onishi, Naoyuki Uchida, Jun Ishikawa, Ken-ichi Matsuoka, Shunsuke Yui, Ken Takase, Toshiro Kawakita, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako
-
Low dose post-transplant cyclophosphamide and sirolimus induce mixed chimerism with CTLA4-Ig or lymphocyte depletion in an MHC-mismatched murine allotransplantation model Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-12 Mariama D. Kabore, Corbin C. McElrath, Mohamed A. E. Ali, Katherine Almengo, Arunakumar Gangaplara, Cameron Fisher, Mauricio A. Barreto, Ahmad Shaikh, Purevdorj B. Olkhanud, Xin Xu, Deanna Gaskin, Maria Lopez-Ocasio, Ankit Saxena, J. Philip McCoy, Courtney D. Fitzhugh
-
Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-10 Ryusuke Yamamoto, Nobuhiro Hiramoto, Ayumi Fujimoto, Hirohito Yamazaki, Takehiko Mori, Naoyuki Uchida, Noriko Doki, Jun Kato, Masashi Nishikubo, Shinichi Kako, Tetsuya Nishida, Shuichi Ota, Makoto Onizuka, Tetsuya Eto, Koichi Onodera, Kazuhiro Ikegame, Ken-ichi Matsuoka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Yasushi Onishi
-
Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-08 Annalisa Paviglianiti, Maud Ngoya, Marta Peña, Ariane Boumendil, Zafer Gülbas, Fabio Ciceri, Francesca Bonifazi, Domenico Russo, Nathalie Fegueux, Friedrich Stolzel, Claude Eric Bulabois, Gerard Socié, Edouard Forcade, Carlo Solano, Hervé Finel, Stephen Robinson, Bertram Glass, Silvia Montoto
-
Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-08 Shuhei Kurosawa, Yoshimitsu Shimomura, Ken Ishiyama, Kyoko Fuse, Yutaka Shimazu, Noriko Doki, Naoyuki Uchida, Masatsugu Tanaka, Satoshi Takahashi, Masatoshi Sakurai, Hikaru Kobayashi, Yuta Katayama, Satoru Takada, Kazutaka Ozeki, Hirohisa Nakamae, Fumihiko Ishimaru, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Hidehiro Itonaga
-
Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-08 Olga Moser, Maud Ngoya, Jacques-Emmanuel Galimard, Arnaud Dalissier, Jean Hugues Dalle, Krzysztof Kalwak, Wilhelm Wössmann, Birgit Burkhardt, Marc Bierings, Marta Gonzalez-Vicent, Lucía López Corral, Karin Mellgren, Andishe Attarbaschi, Jean Henri Bourhis, Kristina Carlson, Selim Corbacioglu, Katarzyna Drabko, Mikael Sundin, Jacek Toporski, Gunnar Cario, Udo Kontny
-
The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-06 Masamitsu Yanada, Shingo Yano, Yachiyo Kuwatsuka, Koji Kawamura, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Hashii, Hideki Goto, Koji Kato, Fumihiko Ishimaru, Atsushi Sato, Makoto Onizuka, Keitaro Matsuo, Yuri Ito, Atsumi Yanagisawa, Marie Ohbiki, Ken Tabuchi, Yoshiko Atsuta, Junya Kanda, Takaaki Konuma
-
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-07 Barbara Meissner, Peter Lang, Peter Bader, Manfred Hoenig, Ingo Müller, Roland Meisel, Johann Greil, Martin G. Sauer, Markus Metzler, Selim Corbacioglu, Birgit Burkhardt, Matthias Wölfl, Brigitte Strahm, Kinan Kafa, Oliver Basu, Holger N. Lode, Bernd Gruhn, Holger Cario, Ann-Kathrin Ozga, Martin Zimmermann, Andrea Jarisch, Rita Beier
-
Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-06 Sofia Oechsler, Nico Gagelmann, Christine Wolschke, Dietlinde Janson, Anita Badbaran, Evgeny Klyuchnikov, Radwan Massoud, Kristin Rathje, Johanna Richter, Mathias Schäfersküpper, Christian Niederwieser, Ameya Kunte, Silke Heidenreich, Francis Ayuk, Nicolaus Kröger
-
Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignancies Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-02-05 Tommy Alfaro Moya, Maria Queralt Salas, Abel Santos Carreira, Eshetu G. Atenafu, Arjun Datt Law, Wilson Lam, Ivan Pasic, Dennis (Dong Hwan) Kim, Fotios V. Michelis, Igor Novitzky Basso, Armin Gerbitz, Jeffrey Howard Lipton, Rajat Kumar, Jonas Mattsson, Auro Viswabandya
-
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-01-31 Meral Beksac, Diderik-Jan Eikema, Linda Koster, Cyrille Hulin, Xavier Poiré, Rose-Marie Hamladji, Tomasz Gromek, Ali Bazarbachi, Zubeyde Nur Ozkurt, Thomas Pabst, Tarek Ben Othman, Jürgen Finke, Olga Pirogova, Depei Wu, Amjad Hayat, Inken Hilgendorf, Eleni Tholouli, Liesbeth C. de Wreede, Stefan Schönland, Laurent Garderet, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J. Hayden, Ibrahim Yakoub-Agha
-
Diagnostic evaluation in bone marrow failure disorders: what have we learnt to help inform the transplant decision in 2024 and beyond? Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-01-30 Giulia Ciangola, Enrico Santinelli, Donal P. McLornan, Simona Pagliuca, Carmelo Gurnari
-
Sequential haplo-identical conditioning transplant regimen for pediatric patients with relapsed or refractory hemophagocytic lymphohistiocytosis Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-01-29 Yan Yue, Shifen Fan, Zhouyang Liu, Fan Jiang, Jiao Chen, Jiayue Qin, Yuan Sun
-
Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-01-29 Hiroya Ichikawa, Kimikazu Yakushijin, Keiji Kurata, Takahiro Tsuji, Naoko Takemoto, Miki Joyce, Yuri Okazoe, Ruri Takahashi, Sakuya Matsumoto, Rina Sakai, Akihito Kitao, Yoshiharu Miyata, Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Mitsuhiro Ito, Tohru Murayama, Hiroshi Matsuoka, Hironobu Minami
-
Selective histone deacetylase inhibitor after allo-HCT for T-cell acute lymphoblastic leukemia or T-cell lymphoma Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-01-23 Weihao Chen, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, He Huang, Yanmin Zhao
-
Letermovir for Cytomegalovirus infection in pediatric patients undergoing allogenic hematopoietic stem cell transplantation: a real-life study by the Infectious Diseases Working Group of Italian Association of Pediatric Hematology-Oncology (AIEOP) Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-01-25 Federica Galaverna, Francesco Baccelli, Daniele Zama, Gloria Tridello, Riccardo Masetti, Elena Soncini, Rossella Mura, Federica Barzaghi, Antonella Colombini, Giulia Prunotto, Maria Rosaria D’Amico, Elisabetta Calore, Alessandra Biffi, Katia Perruccio, Pietro Gasperini, Chiara Oltolini, Francesco Quagliarella, Alice Giacomazzi, Daria Pagliara, Franco Locatelli, Simone Cesaro
-
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-01-25 Chiara De Philippis, Cristina Zucchinetti, Daniele Mannina, Mauro Krampera, Pier Luigi Zinzani, Annalisa Chiappella, Alice di Rocco, Enrico Orcioulo, Maria Chiara Tisi, Flavio Pistolese, Laura Giordano, Armando Santoro, Stefania Bramanti
-
Donor NKG2D rs1049174 polymorphism predicts hematopoietic recovery and event-free survival after single-unit cord blood transplantation in adults Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-01-24 Takaaki Konuma, Megumi Hamatani-Asakura, Maki Monna-Oiwa, Seiko Kato, Masamichi Isobe, Kazuaki Yokoyama, Yasuhito Nannya, Satoshi Takahashi
-
A prognostic score system in adult T‐cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation Bone Marrow Transpl. (IF 4.8) Pub Date : 2024-01-24 Mengyu Xiao, Jianying Zhou, Xiaolu Zhu, Yun He, Fengrong Wang, Yuanyuan Zhang, Xiaodong Mo, Wei Han, Jingzhi Wang, Yu Wang, Huan Chen, Yuhong Chen, Xiangyu Zhao, Yingjun Chang, Lanping Xu, Kaiyan Liu, Xiaojun Huang, Xiaohui Zhang